Red Abbey Labs

Red Abbey Labs (RAL) is a patient-centered, hypothesis and technology driven, capital efficient neuRALinnovation group with a mission to solve degenerative conditions. We are scientists, engineers, clinicians, entrepreneurs, and investors who acknowledge the prevailing science, technology, and business barriers, but are driven by a collective desire to see effective solutions reach patients quickly and cost-effectively. RAL achieves this by pursuing human-derived evidence, enabling technologies, promising hypotheses, and safe therapeutic interventions. In collaboration with our partners, we create translational value through execution and early financing of virtual and semi-virtual research. RAL has initiated work to optimize therapeutic agents for the treatment of neurological conditions. Inspiring hypothesis-driven breakthroughs Exploiting technology-enabled platforms Managing capital-efficient innovation Building patient-centered solutions